A new startup launched at the SynBioBeta conference. The company, called CybergenX, is seeking to integrate AI-powered cybergenetic technology into the synthetic biology field. By doing this, CybergenX is seeking to accelerate the potential of engineering biology in drug manufacturing. The post This Chip Seeks to Transform Drug Manufacturing by Learning...

ŌURA announced two new heart health features on Friday: one that estimates cardiovascular age and one that measures cardio capacity. The post ŌURA Unveils 2 New Features for Heart Health appeared first on MedCity News.

Micropayments provide an additional incentive for patients to complete required tests, procedures, and diary entries, ensuring that sites, sponsors, and CROs are able to collect the required data needed to complete a clinical trial on time and on budget.  The post Small Thank You’s Mean a Lot: The Impact of Micropayments in Clinical Trials appeared...

Check out news from Alpha Sophia, Triomics, In-House Health, and Humanaut Health. The post StartUPDATES: New Developments from Healthcare Startups appeared first on MedCity News.

A Q&A with Naoki Okamura revealed that when it comes to cell and gene therapies, the CEO of Astellas Pharma believes risk-taking is a must for eventual success. The post Astellas CEO Q&A (Part 1): There Is No Playbook on Cell and Gene Therapies appeared first on MedCity News.

On Wednesday, Ascension noticed that a hacker had infiltrated its systems. As the health system works with Mandiant to investigate the incident, clinical services remain disrupted at Ascension facilities across several states. The post Ascension Hospitals Across Several States Are Offline Following Cyberattack appeared first on MedCity News.